APA (7th ed.) Citation

T, P., M, F., M, D., A, A., J, L., A, K., & J, A. (2026). Perioperative antihypertensive medication use is associated with no antifibrotic benefit but higher complications and revision rates following shoulder arthroplasty. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 36(1), . https://doi.org/10.1007/s00590-026-04883-y

Chicago Style (17th ed.) Citation

T, Parmar, Fiandeiro M, Daher M, Adio A, Lawand J, Khan A, and Abboud J. "Perioperative Antihypertensive Medication Use Is Associated with No Antifibrotic Benefit but Higher Complications and Revision Rates Following Shoulder Arthroplasty." European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie 36, no. 1 (2026). https://doi.org/10.1007/s00590-026-04883-y.

MLA (9th ed.) Citation

T, Parmar, et al. "Perioperative Antihypertensive Medication Use Is Associated with No Antifibrotic Benefit but Higher Complications and Revision Rates Following Shoulder Arthroplasty." European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie, vol. 36, no. 1, 2026, https://doi.org/10.1007/s00590-026-04883-y.